Abstract: The present invention describes a new functional biomarker of vascular inflammation and its use in predicting all-cause or cardiac mortality. The invention also provides a method for stratifying patients according to their risk of all-cause or cardiac mortality using data gathered from a computer tomography scans of a blood vessel to determine a specific combination of structural and functional biomarkers of vascular inflammation and disease.

Abstract: The present invention describes a new functional biomarker of vascular inflammation and its use in predicting all-cause or cardiac mortality. The invention also provides a method for stratifying patients according to their risk of all-cause or cardiac mortality using data gathered from a computer tomography scans of a blood vessel to determine a specific combination of structural and functional biomarkers of vascular inflammation and disease.

Abstract: The invention relates to specific active compositions for producing highly viscous laundry and cleaning formulations, particularly laundry fabric softeners, to a method for the production thereof and to said laundry and cleaning formulations. High viscosity can be achieved in the products according to the invention despite a low concentration of active compositions and without using additional thickeners.

Abstract: The present invention describes a new functional biomarker of vascular inflammation and its use in predicting all-cause or cardiac mortality. The invention also provides a method for stratifying patients according to their risk of all-cause or cardiac mortality using data gathered from a computer tomography scans of a blood vessel to determine a specific combination of structural and functional biomarkers of vascular inflammation and disease.

Abstract: The present invention relates to methods for assessing or obtaining an indication of vascular pressure associated with organs or visceral tissues of the body by using MRI imaging methods. The invention particularly relates to methods for assessing or obtaining an indication of portal hypertension using Magnetic Resonance T1, or T1 and T2* relaxometry, and T1, T2, and/or T2* mapping of the liver or spleen.

Abstract: The invention relates to compositions comprising A) at least one hybrid quat and B) at least one fatty alcohol.

Abstract: The present invention describes a new functional biomarker of vascular inflammation and its use in predicting all-cause or cardiac mortality. The invention also provides a method for stratifying patients according to their risk of all-cause or cardiac mortality using data gathered from a computer tomography scans of a blood vessel to determine a specific combination of structural and functional biomarkers of vascular inflammation and disease.

Abstract: The present invention describes a new functional biomarker of vascular inflammation and its use in predicting all-cause or cardiac mortality. The invention also provides a method for stratifying patients according to their risk of all-cause or cardiac mortality using data gathered from a computer tomography scans of a blood vessel to determine a specific combination of structural and functional biomarkers of vascular inflammation and disease.

Abstract: The invention relates to specific active compositions for producing highly viscous laundry and cleaning formulations, particularly laundry fabric softeners, to a method for the production thereof and to said laundry and cleaning formulations. High viscosity can be achieved in the products according to the invention despite a low concentration of active compositions and without using additional thickeners.

Abstract: The invention relates to compositions comprising A) at least one hybrid quat and B) at least one fatty alcohol.

Abstract: Methods for volumetric characterisation of perivascular adipose tissue use data collected by computed tomography (CT) scanning. The volumetric characterisation of perivascular adipose tissue allows the inflammatory status of underlying blood vessels to be established by CT scanning. This is of use in the diagnosis, prognosis and treatment of coronary and vascular disease.

Abstract: The present invention relates to methods for assessing or obtaining an indication of vascular pressure associated with organs or visceral tissues of the body by using MRI imaging methods. The invention particularly relates to methods for assessing or obtaining an indication of portal hypertension using Magnetic Resonance T1, or T1 and T2* relaxometry, and T1, T2 and/or T2* mapping of the liver or spleen.

Abstract: Described herein are systems and methods for performing multi-parametric diagnosis for liver disease. Systems and methods as described herein can include positioning a subject-in association with a medical imaging device and using the medical imaging device to measure the subject's liver for extracellular fluid and iron content. Systems and methods as described herein can further include determining whether iron overload may be indicated or present from the measurement for iron content, and if indicated, correcting the measurement for extra cellular fluid. Systems and methods as described herein can further include measuring the liver for hepatic lipid content (HLC). Systems and methods as described herein can determine the presence or absence of liver disease from measurements obtained from a subject. In certain embodiments, the medical imaging device is a magnetic resonance (MR) scanner. In certain embodiments, the liver is measured for iron overload.

Abstract: The present invention describes a new functional biomarker of vascular inflammation and its use in predicting all-cause or cardiac mortality. The invention also provides a method for stratifying patients according to their risk of all-cause or cardiac mortality using data gathered from a computer tomography scans of a blood vessel to determine a specific combination of structural and functional biomarkers of vascular inflammation and disease.

Abstract: The present disclosure provides systems and methods for universal mapping of T1 in abdominal organs using cardiac gating. A region of interest is selected for mapping or imaging. A determination is made whether any one or more of heart associated motion, high heart rate and irregular heart beat are detected in the region of interest. A multi-pathway gating of T1 maps is then employed providing a universal method of T1 mapping of moving as well as non-moving visceral organs.

Abstract: The present invention relates to methods for assessing or obtaining an indication of vascular pressure associated with organs or visceral tissues of the body by using MRI imaging methods. The invention particularly relates to methods for assessing or obtaining an indication of portal hypertension using Magnetic Resonance T1, or T1 and T2* relaxometry, and T1, T2 and/or T2* mapping of the liver or spleen.

Abstract: The present invention provides dye mixtures containing at least one dye of formula (I) and at least one dye of formula (II) where T1, T2, R1 to R9 and n are each as defined in claim 1, processes for their preparation and their use.

Abstract: The present invention relates to stripping devices by way of which a cable sheath can be removed from a cable end and in this way the cable core can be exposed. Such a stripping device for stripping a cable sheath from a cable comprises a first cutter half and a second cutter half which are movable towards one another in a first direction. The mutually facing lateral surfaces of the first and second cutter halves are spaced apart from one another at a spacing in a second direction substantially perpendicular to the first direction, and a voltage is applied to the first cutter half and the second cutter half. Furthermore, the stripping device has an evaluation unit connected to the first cutter half and the second cutter half, said evaluation unit being able to detect a current flow through the first cutter half and/or the second cutter half (10).

Abstract: The present disclosure provides systems and methods for universal mapping of T1 in abdominal organs using cardiac gating. A region of interest is selected for mapping or imaging. A determination is made whether any one or more of heart associated motion, high heart rate and irregular heart beat are detected in the region of interest. A multi-pathway gating of T1 maps is then employed providing a universal method of T1 mapping of moving as well as non-moving visceral organs.

Abstract: The present invention provides dyes of the general formula (I) where D, R1 to R7 and n are each as defined in claim 1, processes for their preparation and their use.